Prenetics Global Limited (PRE)
NASDAQ: PRE · Real-Time Price · USD
8.00
-0.07 (-0.87%)
At close: Aug 1, 2025, 4:00 PM
7.90
-0.10 (-1.25%)
After-hours: Aug 1, 2025, 4:10 PM EDT

Prenetics Global Revenue

Prenetics Global had revenue of $17.31M in the quarter ending March 31, 2025, with 169.93% growth. This brings the company's revenue in the last twelve months to $41.52M, up 78.72% year-over-year. In the year 2024, Prenetics Global had annual revenue of $30.62M with 40.83% growth.

Revenue (ttm)
$41.52M
Revenue Growth
+78.72%
P/S Ratio
2.45
Revenue / Employee
$145,684
Employees
285
Market Cap
104.27M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202430.62M8.88M40.83%
Dec 31, 202321.74M8.58M65.17%
Dec 31, 202213.16M631.26K5.04%
Dec 31, 202112.53M-52.65M-80.77%
Dec 31, 202065.18M55.95M605.93%
Dec 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie57.37B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company49.00B
Novo Nordisk43.92B
Revenue Rankings